Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glucosidase activity	KL SI LCT	3.50e-05	15	87	3	GO:0015926
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential	KCNH1 KCNJ6 KCNJ11	5.20e-05	17	87	3	GO:0099508
GeneOntologyMolecularFunction	threonine-tRNA ligase activity	TARS3 TARS1	5.61e-05	3	87	2	GO:0004829
GeneOntologyMolecularFunction	hydrolase activity, hydrolyzing O-glycosyl compounds	KL MAN2C1 SI LCT LYZ	8.75e-05	103	87	5	GO:0004553
GeneOntologyMolecularFunction	inward rectifier potassium channel activity	KCNH2 KCNJ6 KCNJ11	2.42e-04	28	87	3	GO:0005242
GeneOntologyMolecularFunction	beta-glucosidase activity	KL LCT	2.78e-04	6	87	2	GO:0008422
GeneOntologyMolecularFunction	ribosomal protein S6 kinase activity	RPS6KB1 RPS6KB2	3.89e-04	7	87	2	GO:0004711
GeneOntologyMolecularFunction	hydrolase activity, acting on glycosyl bonds	KL MAN2C1 SI LCT LYZ	4.18e-04	144	87	5	GO:0016798
GeneOntologyMolecularFunction	voltage-gated monoatomic cation channel activity	CATSPER1 KCNH1 KCNH2 KCNJ6 KCNJ11	5.35e-04	152	87	5	GO:0022843
GeneOntologyMolecularFunction	voltage-gated potassium channel activity	KCNH1 KCNH2 KCNJ6 KCNJ11	1.03e-03	102	87	4	GO:0005249
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity	CATSPER1 KCNH1 KCNH2 KCNJ6 KCNJ11	1.20e-03	182	87	5	GO:0005244
GeneOntologyMolecularFunction	voltage-gated channel activity	CATSPER1 KCNH1 KCNH2 KCNJ6 KCNJ11	1.26e-03	184	87	5	GO:0022832
GeneOntologyMolecularFunction	carboxypeptidase activity	AGBL2 ACE AGTPBP1	1.27e-03	49	87	3	GO:0004180
GeneOntologyCellularComponent	cell surface	EPHB6 OTOA VLDLR CD1C DUOX1 ACHE KCNH1 KCNH2 KCNJ6 RPS6KB1 MR1 CCR5 LCT ACE IL17RB	4.33e-05	1111	86	15	GO:0009986
GeneOntologyCellularComponent	axolemma	KCNH1 KCNJ11 MAPK8IP3	8.47e-05	21	86	3	GO:0030673
Domain	Ribosomal_S6_kinase	RPS6KB1 RPS6KB2	2.14e-05	2	87	2	IPR016238
Domain	ThrRS_core	TARS3 TARS1	6.42e-05	3	87	2	IPR033728
Domain	Thr-tRNA-ligase_IIa	TARS3 TARS1	6.42e-05	3	87	2	IPR002320
Domain	Glyco_hydro_1_N_CS	KL LCT	1.28e-04	4	87	2	IPR033132
Domain	Glyco_hydro_1_AS	KL LCT	1.28e-04	4	87	2	IPR018120
Domain	GLYCOSYL_HYDROL_F1_2	KL LCT	2.13e-04	5	87	2	PS00653
Domain	GLYCOSYL_HYDROL_F1_1	KL LCT	2.13e-04	5	87	2	PS00572
Domain	Glyco_hydro_1	KL LCT	2.13e-04	5	87	2	PF00232
Domain	Glyco_hydro_1	KL LCT	2.13e-04	5	87	2	IPR001360
Domain	TGS	TARS3 TARS1	3.18e-04	6	87	2	IPR004095
Domain	TGS	TARS3 TARS1	3.18e-04	6	87	2	PF02824
Domain	-	EPHB6 PCSK5 CUL9 FBXO27	3.74e-04	73	87	4	2.60.120.260
Domain	TGS-like	TARS3 TARS1	4.44e-04	7	87	2	IPR012676
Domain	tRNA_SAD	TARS3 TARS1	4.44e-04	7	87	2	SM00863
Domain	tRNA_SAD	TARS3 TARS1	4.44e-04	7	87	2	IPR012947
Domain	tRNA_SAD	TARS3 TARS1	4.44e-04	7	87	2	PF07973
Domain	Thr/Ala-tRNA-synth_IIc_edit	TARS3 TARS1	5.90e-04	8	87	2	IPR018163
Domain	Pkinase_C	RPS6KB1 RPS6KB2 SGK2	6.76e-04	37	87	3	IPR017892
Domain	HGTP_anticodon	TARS3 TARS1	7.56e-04	9	87	2	PF03129
Domain	PAS_9	KCNH1 KCNH2	9.42e-04	10	87	2	PF13426
Domain	Galactose-bd-like	EPHB6 PCSK5 CUL9 FBXO27	9.73e-04	94	87	4	IPR008979
Domain	Pkinase_C	RPS6KB1 RPS6KB2 SGK2	9.83e-04	42	87	3	PF00433
Domain	aa-tRNA-synt_IIb	TARS3 TARS1	1.15e-03	11	87	2	IPR002314
Domain	tRNA-synt_2b	TARS3 TARS1	1.15e-03	11	87	2	PF00587
Domain	-	TARS3 TARS1	1.15e-03	11	87	2	3.40.50.800
Domain	Beta-grasp_dom	TARS3 TARS1	1.88e-03	14	87	2	IPR012675
Domain	K_chnl_volt-dep_EAG/ELK/ERG	KCNH1 KCNH2	1.88e-03	14	87	2	IPR003938
Domain	-	TARS3 TARS1	1.88e-03	14	87	2	3.10.20.30
Domain	Anticodon-bd	TARS3 TARS1	1.88e-03	14	87	2	IPR004154
Domain	Glycoside_hydrolase_SF	KL SI LCT	1.93e-03	53	87	3	IPR017853
Domain	AGC-kinase_C	RPS6KB1 RPS6KB2 SGK2	2.26e-03	56	87	3	IPR000961
Domain	AGC_KINASE_CTER	RPS6KB1 RPS6KB2 SGK2	2.26e-03	56	87	3	PS51285
Domain	S_TK_X	RPS6KB1 RPS6KB2 SGK2	2.26e-03	56	87	3	SM00133
Domain	K_chnl_inward-rec_Kir_cyto	KCNJ6 KCNJ11	2.47e-03	16	87	2	IPR013518
Domain	IRK	KCNJ6 KCNJ11	2.47e-03	16	87	2	PF01007
Domain	-	KCNJ6 KCNJ11	2.47e-03	16	87	2	2.60.40.1400
Domain	K_chnl_inward-rec_Kir	KCNJ6 KCNJ11	2.47e-03	16	87	2	IPR016449
Domain	Gal_mutarotase_SF_dom	MAN2C1 SI	2.79e-03	17	87	2	IPR011013
Domain	aa-tRNA-synth_II	TARS3 TARS1	3.13e-03	18	87	2	IPR006195
Domain	AA_TRNA_LIGASE_II	TARS3 TARS1	3.13e-03	18	87	2	PS50862
Domain	Peptidase_M14	AGBL2 AGTPBP1	5.09e-03	23	87	2	PF00246
Domain	Peptidase_M14	AGBL2 AGTPBP1	5.09e-03	23	87	2	IPR000834
Domain	-	CD1C MR1	5.54e-03	24	87	2	3.30.500.10
Domain	PAS-assoc_C	KCNH1 KCNH2	5.54e-03	24	87	2	IPR000700
Domain	MHC_I-like_Ag-recog	CD1C MR1	5.54e-03	24	87	2	IPR011161
Domain	PAS	KCNH1 KCNH2	6.00e-03	25	87	2	PF00989
Domain	Ephrin_rec_like	EPHB6 PCSK5	6.00e-03	25	87	2	SM01411
Pathway	KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY	VLDLR RPS6KB1 RPS6KB2	4.90e-05	15	69	3	M47663
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	EPHB6 PCSK5 SETD1B KCNH1 KCNH2 RPS6KB1 RPS6KB2 RIOK3 KDM1B TARS1 STT3B SGK2	3.20e-07	730	88	12	34857952
Pubmed	Loss of threonyl-tRNA synthetase-like protein Tarsl2 has little impact on protein synthesis but affects mouse development.	TARS3 TARS1	6.33e-06	2	88	2	37059185
Pubmed	Unique cerebellar phenotype combining granule and Purkinje cell loss: morphological evidence for weaver* pcd double mutant mice.	KCNJ6 AGTPBP1	6.33e-06	2	88	2	2027034
Pubmed	Activation of Mechanistic Target of Rapamycin (mTOR) in Human Endothelial Cells Infected with Pathogenic Spotted Fever Group Rickettsiae.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	33003310
Pubmed	Absence of direct cyclic nucleotide modulation of mEAG1 and hERG1 channels revealed with fluorescence and electrophysiological methods.	KCNH1 KCNH2	6.33e-06	2	88	2	19671703
Pubmed	Serotonin-immunoreactivity in the cerebellum of two neurological mutant mice and the corresponding wild-type genetic stocks.	KCNJ6 AGTPBP1	6.33e-06	2	88	2	1781951
Pubmed	Different interactomes for p70-S6K1 and p54-S6K2 revealed by proteomic analysis.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	27493124
Pubmed	hERG channel blockade by externally applied quaternary ammonium derivatives.	KCNH1 KCNH2	6.33e-06	2	88	2	21320466
Pubmed	Differential expression of hERG1 channel isoforms reproduces properties of native I(Kr) and modulates cardiac action potential characteristics.	KCNH1 KCNH2	6.33e-06	2	88	2	20126398
Pubmed	K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons.	KCNJ6 KCNJ11	6.33e-06	2	88	2	16299504
Pubmed	S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	17550782
Pubmed	Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	18174371
Pubmed	Solanine inhibits proliferation and promotes apoptosis of the human leukemia cells by targeting the miR-16/Bcl-2 axis.	BCL2 GDE1	6.33e-06	2	88	2	32862612
Pubmed	Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2.	CCR5 BCL2	6.33e-06	2	88	2	12751031
Pubmed	Modulation of GABA(A) receptor subunit mRNA levels in olivocerebellar neurons of purkinje cell degeneration and weaver mutant mice.	KCNJ6 AGTPBP1	6.33e-06	2	88	2	10800965
Pubmed	Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	9822608
Pubmed	Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses.	IL1R2 LYZ	6.33e-06	2	88	2	28235865
Pubmed	Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	20953835
Pubmed	Plasticity of GABAergic terminals in Deiters' nucleus of weaver mutant and normal mice: a quantitative light microscopic study.	KCNJ6 AGTPBP1	6.33e-06	2	88	2	1446244
Pubmed	Klotho sensitivity of the hERG channel.	KL KCNH2	6.33e-06	2	88	2	23603386
Pubmed	Metabolic control by S6 kinases depends on dietary lipids.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	22412899
Pubmed	Molecular biology of aging.	KL BCL2	6.33e-06	2	88	2	9988222
Pubmed	Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	18758466
Pubmed	A threonyl-tRNA synthetase-like protein has tRNA aminoacylation and editing activities.	TARS3 TARS1	6.33e-06	2	88	2	29579307
Pubmed	The use of Bcl-2 over-expression to stabilize hybridomas specific to the HERG potassium channel.	KCNH2 BCL2	6.33e-06	2	88	2	22107967
Pubmed	A family of potassium channel genes related to eag in Drosophila and mammals.	KCNH1 KCNH2	6.33e-06	2	88	2	8159766
Pubmed	Functions and regulation of the 70kDa ribosomal S6 kinases.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	20932932
Pubmed	Lesion-specific pattern of immunocytochemical distribution of growth-associated protein B-50 (GAP-43) in the cerebellum of Weaver and PCD-mutant mice: lack of B-50 involvement in neuroplasticity of Purkinje cell terminals?	KCNJ6 AGTPBP1	6.33e-06	2	88	2	7932867
Pubmed	Unique and Redundant Functions of p70 Ribosomal S6 Kinase Isoforms Regulate Mesenchymal Cell Proliferation and Migration in Pulmonary Fibrosis.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	27438654
Pubmed	Gene amplification of ribosomal protein S6 kinase-1 and -2 in gastric cancer.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	23393338
Pubmed	Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	20080710
Pubmed	Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis.	TNFSF11 BCL2	6.33e-06	2	88	2	35183115
Pubmed	Differential regulation of bcl-2, bax, c-fos, junB, and krox-24 expression in the cerebellum of Purkinje cell degeneration mutant mice.	BCL2 AGTPBP1	6.33e-06	2	88	2	7563251
Pubmed	Protein kinase C phosphorylates ribosomal protein S6 kinase betaII and regulates its subcellular localization.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	12529391
Pubmed	Molecular cloning and characterization of a novel p70 S6 kinase, p70 S6 kinase beta containing a proline-rich region.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	9804755
Pubmed	S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	15060135
Pubmed	Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation.	RPS6KB1 RPS6KB2	6.33e-06	2	88	2	18846252
Pubmed	The tripartite interaction of phosphate, autophagy, and αKlotho in health maintenance.	KL BCL2	1.90e-05	3	88	2	31908069
Pubmed	Calbindin D-28k in the lateral vestibular nucleus of mutant mice as a tool to reveal Purkinje cell plasticity.	KCNJ6 AGTPBP1	1.90e-05	3	88	2	8177535
Pubmed	Mechanism of Bcl-2 and Bcl-X(L) inhibition of NLRP1 inflammasome: loop domain-dependent suppression of ATP binding and oligomerization.	NLRP1 BCL2	1.90e-05	3	88	2	19223583
Pubmed	mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia.	RPS6KB1 RPS6KB2	1.90e-05	3	88	2	19535330
Pubmed	The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome.	KCNH1 KCNH2	1.90e-05	3	88	2	20116193
Pubmed	Specific interaction between S6K1 and CoA synthase: a potential link between the mTOR/S6K pathway, CoA biosynthesis and energy metabolism.	RPS6KB1 RPS6KB2	1.90e-05	3	88	2	15589845
Pubmed	Pro-thyrotropin-releasing hormone concentrations in the brain of ataxic mice.	KCNJ6 AGTPBP1	1.90e-05	3	88	2	2123001
Pubmed	Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade.	RPS6KB1 RPS6KB2	1.90e-05	3	88	2	18006852
Pubmed	Expression of c-kit, a proto-oncogene of the murine W locus, in cerebella of normal and neurological mutant mice: immunohistochemical and in situ hybridization analysis.	KCNJ6 AGTPBP1	1.90e-05	3	88	2	1282111
Pubmed	Disruption of the beclin 1-BCL2 autophagy regulatory complex promotes longevity in mice.	KL BCL2	1.90e-05	3	88	2	29849149
Pubmed	Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases.	RPS6KB1 RPS6KB2	1.90e-05	3	88	2	15071500
Pubmed	Cbln1 binds to specific postsynaptic sites at parallel fiber-Purkinje cell synapses in the cerebellum.	KCNJ6 AGTPBP1	1.90e-05	3	88	2	19200061
Pubmed	Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer.	RPS6KB1 RPS6KB2	1.90e-05	3	88	2	32054043
Pubmed	Beclin 1/Bcl-2 complex-dependent autophagy activity modulates renal susceptibility to ischemia-reperfusion injury and mediates renoprotection by Klotho.	KL BCL2	1.90e-05	3	88	2	31984794
Pubmed	mTORC1 directly phosphorylates and regulates human MAF1.	RPS6KB1 RPS6KB2	1.90e-05	3	88	2	20516213
Pubmed	Brief report: increased apoptosis in advanced atherosclerotic lesions of Apoe-/- mice lacking macrophage Bcl-2.	BCL2 LYZ	1.90e-05	3	88	2	18988889
Pubmed	Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties.	CCR5 LYZ	1.90e-05	3	88	2	32001710
Pubmed	Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.	TNFSF11 LYZ	1.90e-05	3	88	2	27596806
Pubmed	DNA fragmentation and activation of c-Jun in the cerebellum of mutant mice (weaver, Purkinje cell degeneration).	KCNJ6 AGTPBP1	1.90e-05	3	88	2	8541477
Pubmed	Transplantation of cerebellar anlagen to hosts with genetic cerebellocortical atrophy.	KCNJ6 AGTPBP1	1.90e-05	3	88	2	3619071
Pubmed	Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin.	MR1 LYZ	1.90e-05	3	88	2	37595566
Pubmed	mGluR-dependent long-term depression is associated with increased phosphorylation of S6 and synthesis of elongation factor 1A but remains expressed in S6K-deficient mice.	RPS6KB1 RPS6KB2	1.90e-05	3	88	2	18316404
Pubmed	Macrophage-intrinsic DUOX1 contributes to type 2 inflammation and mucus metaplasia during allergic airway disease.	DUOX1 LYZ	1.90e-05	3	88	2	35654836
Pubmed	Vestibular ganglion neurons survive the loss of their cerebellar targets.	KCNJ6 AGTPBP1	1.90e-05	3	88	2	9926858
Pubmed	OGT suppresses S6K1-mediated macrophage inflammation and metabolic disturbance.	RPS6KB1 LYZ	1.90e-05	3	88	2	32601203
Pubmed	Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program.	RPS6KB1 RPS6KB2	1.90e-05	3	88	2	23318442
Pubmed	S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response.	RPS6KB1 RPS6KB2	3.79e-05	4	88	2	20657550
Pubmed	Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.	KL TNFSF11	3.79e-05	4	88	2	15564564
Pubmed	The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy.	RPS6KB1 RPS6KB2	3.79e-05	4	88	2	22087027
Pubmed	S6 kinase 1 is required for rapamycin-sensitive liver proliferation after mouse hepatectomy.	RPS6KB1 RPS6KB2	3.79e-05	4	88	2	21633171
Pubmed	Combining information from common type 2 diabetes risk polymorphisms improves disease prediction.	KCNJ11 LCT	3.79e-05	4	88	2	17020404
Pubmed	Association of 1166A>C AT1R, -1562C>T MMP-9, ACE I/D, and CCR5Δ32 Polymorphisms with Abdominal Aortic Aneurysm in Croatian Patients.	CCR5 ACE	3.79e-05	4	88	2	27533781
Pubmed	Intestinal stem cells contribute to the maturation of the neonatal small intestine and colon independently of digestive activity.	SI LYZ	3.79e-05	4	88	2	28860595
Pubmed	PKA-dependent phosphorylation of ribosomal protein S6 does not correlate with translation efficiency in striatonigral and striatopallidal medium-sized spiny neurons.	RPS6KB1 RPS6KB2	3.79e-05	4	88	2	25762659
Pubmed	NeuN, a neuronal specific nuclear protein in vertebrates.	KCNJ6 AGTPBP1	3.79e-05	4	88	2	1483388
Pubmed	LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer.	CCR5 LYZ	3.79e-05	4	88	2	37442140
Pubmed	RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.	TNFSF11 LYZ	3.79e-05	4	88	2	28438834
Pubmed	PLRG1 is an essential regulator of cell proliferation and apoptosis during vertebrate development and tissue homeostasis.	BCL2 PLRG1	3.79e-05	4	88	2	19307306
Pubmed	Histone acetyltransferases interact with and acetylate p70 ribosomal S6 kinases in vitro and in vivo.	RPS6KB1 RPS6KB2	3.79e-05	4	88	2	19961954
Pubmed	Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis.	RPS6KB1 RPS6KB2	3.79e-05	4	88	2	21444676
Pubmed	Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)- and ribosomal protein S6K-mediated signals.	RPS6KB1 RPS6KB2	3.79e-05	4	88	2	19289497
Pubmed	Regulation of hERG and hEAG channels by Src and by SHP-1 tyrosine phosphatase via an ITIM region in the cyclic nucleotide binding domain.	KCNH1 KCNH2	3.79e-05	4	88	2	24587194
Pubmed	ZRF1 is a novel S6 kinase substrate that drives the senescence programme.	RPS6KB1 RPS6KB2	3.79e-05	4	88	2	28242756
Pubmed	Functional segregation and emerging role of cilia-related cytosolic carboxypeptidases (CCPs).	AGBL2 AGTPBP1	3.79e-05	4	88	2	23085998
Pubmed	[Elevated immunoreactive-somatostatin levels in the brain of ataxic mutant mice].	KCNJ6 AGTPBP1	3.79e-05	4	88	2	2901364
Pubmed	Developmental expression and intracellular location of P400 protein characteristic of Purkinje cells in the mouse cerebellum.	KCNJ6 AGTPBP1	3.79e-05	4	88	2	2707487
Pubmed	The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity.	RPS6KB1 RPS6KB2	3.79e-05	4	88	2	16763566
Pubmed	Ataxia-ameliorating effects of YM-14673, a potent analog of thyrotropin releasing hormone, in ataxic mutant mice.	KCNJ6 AGTPBP1	3.79e-05	4	88	2	8013566
Pubmed	Cellular distribution of the RNA transcripts of a newly discovered gene in the brain of normal, weaver, Purkinje cell degeneration and reeler mutant mice as evidenced by in situ hybridization histochemistry.	KCNJ6 AGTPBP1	3.79e-05	4	88	2	8326827
Pubmed	Fibroblast growth factor 23 and 25(OH)D levels are related to abdominal obesity and cardiovascular risk in patients with polycystic ovarian syndrome.	KL TNFSF11	3.79e-05	4	88	2	31709849
Pubmed	GABAA/benzodiazepine receptor alpha 6 subunit mRNA in granule cells of the cerebellar cortex and cochlear nuclei: expression in developing and mutant mice.	KCNJ6 AGTPBP1	3.79e-05	4	88	2	8132866
Pubmed	RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146.	TNFSF11 LYZ	3.79e-05	4	88	2	28287403
Pubmed	Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons.	KCNJ6 KCNJ11	3.79e-05	4	88	2	10022826
Pubmed	mTOR Inhibition Subdues Milk Disorder Caused by Maternal VLDLR Loss.	VLDLR LYZ	3.79e-05	4	88	2	28591574
Pubmed	The Purkinje cell class may extend beyond the cerebellum.	KCNJ6 AGTPBP1	3.79e-05	4	88	2	2077109
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	EPHB6 NOP58 RTTN MRPS14 USP40 CUL9 AGTPBP1 DNAH1	3.83e-05	496	88	8	31343991
Pubmed	Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.	NOP58 SETD1B WNT2 NLRP1 BCL2 IL17RB	5.01e-05	257	88	6	30945288
Pubmed	Regulation of Histone Acetylation on Expression Profiles of Potassium Channels During Cardiomyocyte Differentiation From Mouse Embryonic Stem Cells.	KCNH2 KCNJ11	6.30e-05	5	88	2	28464250
Pubmed	Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection.	RPS6KB1 RPS6KB2	6.30e-05	5	88	2	21501832
Pubmed	RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice.	TNFSF11 LYZ	6.30e-05	5	88	2	27733688
Pubmed	A role for succinate dehydrogenase genes in low chemoresponsiveness to hypoxia?	ACE SDHC	6.30e-05	5	88	2	19768395
Pubmed	Association between IL4 (-590), ACE (I)/(D), CCR5 (Delta32), CTLA4 (+49) and IL1-RN (VNTR in intron 2) gene polymorphisms and vitiligo.	CCR5 ACE	6.30e-05	5	88	2	19129082
Pubmed	The mTOR pathway negatively controls ATM by up-regulating miRNAs.	RPS6KB1 RPS6KB2	6.30e-05	5	88	2	23818585
ToppCell	distal-2-Hematologic-EREG+_Dendritic\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD1C MB21D2 IL1R2 GNA15 CCR5 BCL2 LYZ	1.30e-07	197	88	7	6fcca7c071e35786b715adeb18be317d34315d7e
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA ARFGEF3 FAT3 NAV3 SFI1 DNAH1	1.77e-06	184	88	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA ARFGEF3 FAT3 NAV3 SFI1 DNAH1	1.77e-06	184	88	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA ARFGEF3 FAT3 NAV3 SFI1 DNAH1	1.77e-06	184	88	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARFGEF3 KCNJ6 CUL9 SI IL17RB NUTM2G	1.83e-06	185	88	6	d42f6722a6771752cd744146a09e2ead9b7252bc
ToppCell	distal-Hematologic-EREG+_Dendritic-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD1C MB21D2 IL1R2 GNA15 BCL2 LYZ	2.55e-06	196	88	6	c17bb7b3992bfec194bfa310f201a5c64b35868e
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF11 MTERF1 MR1 FBXO27 IL17RB	1.60e-05	159	88	5	e967b557fe6ae4879d36f62c0297cbf6a2ad1ce9
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF11 MTERF1 MR1 FBXO27 IL17RB	1.60e-05	159	88	5	9db971130509c62d439e0cab16588a4d994d7aa0
ToppCell	3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KCNH1 KCNJ6 FAT3 NAV3 BCL2	1.75e-05	162	88	5	9a18286e361e1dd18e6f943ce27db58b199fb6e4
ToppCell	3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KCNH1 KCNJ6 FAT3 NAV3 BCL2	1.75e-05	162	88	5	3395e4dffdb9304d157c325e1fc0f12b433c7bd3
ToppCell	3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KCNH1 KCNJ6 FAT3 NAV3 BCL2	1.75e-05	162	88	5	9522af31f6b2f3cb81b6b84bd08353eea504d1d6
ToppCell	3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KCNH1 KCNJ6 FAT3 NAV3 BCL2	1.75e-05	162	88	5	40265af9b36fd144a8577b8dacccd4fc0888a593
ToppCell	Bronchial_Biopsy-Epithelial-Ionocytes\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	KCNH1 KCNH2 FAT3 NAV3 BCL2	2.47e-05	174	88	5	7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb
ToppCell	droplet-Fat-Scat-21m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 DUOX1 KCNH1 WNT2 AGBL2	2.75e-05	178	88	5	5fc9f41609735b972a2cd0830182d13742cd5bf5
ToppCell	PCW_05-06-Immune_Lymphocytic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CD1C TNFSF11 GNA15 CCR5 LYZ	2.98e-05	181	88	5	bd99c5849bb4979c891898312cb9f602c6831b23
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD1C IL1R2 ACHE LYZ GLTPD2	3.06e-05	182	88	5	9a68d3bd1cc9139de9e9e711c249d47ade826bb1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD1C IL1R2 ACHE LYZ GLTPD2	3.06e-05	182	88	5	d57d18732aa6fb7b2d430601568f9ba525ac6e3c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD1C IL1R2 ACHE LYZ GLTPD2	3.06e-05	182	88	5	c3fb1460160744144aa31afc76c0a4d42ebdeb91
ToppCell	3'-Adult-SmallIntestine-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK5 SI LCT ACE GLTPD2	3.22e-05	184	88	5	ed7a8e79e5723a5f5a03f542203d9e50bdef5f50
ToppCell	moderate-Epithelial-Ionocyte\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KCNH1 KCNH2 FAT3 CLDN20 BCL2	3.66e-05	189	88	5	6011b747e27d61d222380a7bffdd921a68e9b657
ToppCell	critical-Epithelial-Ionocyte\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KCNH1 KCNH2 FAT3 NAV3 BCL2	3.76e-05	190	88	5	05a2c3549b68f49081723bf35db14974274419d5
ToppCell	Control-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	CD1C MB21D2 IL1R2 GNA15 BCL2	3.85e-05	191	88	5	11dfd8f38beb294f42710cfbd355cb089e1023c0
ToppCell	PSB-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KCNH1 KCNH2 FAT3 NAV3 BCL2	3.85e-05	191	88	5	8f4637e801554e2343b974fe7794f01dd2151418
ToppCell	COPD-Myeloid-cDC2\|COPD / Disease state, Lineage and Cell class	WDR74 CD1C MB21D2 IL1R2 GNA15	3.85e-05	191	88	5	2af6e4a6bd1f2193ece2131c3b7d976dd23a6966
ToppCell	COPD-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	WDR74 CD1C MB21D2 IL1R2 GNA15	3.85e-05	191	88	5	4e4887175200a57e1b041f2f131e3df774df3509
ToppCell	COPD-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	WDR74 CD1C IL1R2 GNA15 BCL2	3.95e-05	192	88	5	984cdc2f1d93e164bc946d63f58dacb629f82eb7
ToppCell	10x5'-Liver-Myeloid_Dendritic\|Liver / Manually curated celltypes from each tissue	CD1C IL1R2 GNA15 FBXO27 LYZ	4.15e-05	194	88	5	e6391bc7073831847c469ef0b0c437118e1f151f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CD1C IL1R2 GNA15 BCL2 LYZ	4.25e-05	195	88	5	9c6bed8414633813e1655bbeaab682fb296958a9
ToppCell	distal-Hematologic-EREG+_Dendritic\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD1C MB21D2 IL1R2 GNA15 LYZ	4.36e-05	196	88	5	14c6870d125fc2bdacf4199883399cec0dd3f569
ToppCell	390C-Myeloid-Dendritic\|390C / Donor, Lineage, Cell class and subclass (all cells)	CD1C IL1R2 ACHE GNA15 LYZ	4.46e-05	197	88	5	424526c94b9a73c1c28ddc65dfba53aba5c6b2d2
ToppCell	5'-Adult-SmallIntestine-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK5 SI LCT ACE LYZ	4.57e-05	198	88	5	8d629492d2199de8e036c19e9dacceb9c9e721a0
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SGMS2 CATSPER1 IL1R2 GNA15 LYZ	4.57e-05	198	88	5	dc59442e6a5127d3071a036c206732a21e456a17
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CD1C IL1R2 GNA15 BCL2 LYZ	4.57e-05	198	88	5	4682f6e7b18b3fcc4066fb448f9756c32dce0be4
ToppCell	LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_only / Treatment groups by lineage, cell group, cell type	VLDLR ZNF789 CUL9 NLRP1 GNA15	4.57e-05	198	88	5	d205dfcfe1f20e1e21bf84759e723d9e6e610a5c
ToppCell	tumor_Lung-Myeloid_cells-CD1c+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	CD1C DUOX1 IL1R2 GNA15 BCL2	4.57e-05	198	88	5	edd8ad006c4c7516491e52cc8adad20297837e5b
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CD1C CATSPER1 IL1R2 GNA15 LYZ	4.57e-05	198	88	5	115f564af8d7b89ac0331d3831faaef694043fd4
ToppCell	5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK5 SI LCT ACE GLTPD2	4.57e-05	198	88	5	6e6af8fad09f8e48b3f2ce463d5773b6a69864d1
ToppCell	5'-Adult-SmallIntestine\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK5 SI LCT ACE LYZ	4.68e-05	199	88	5	a5fffe381be1ba7d192b68d1d3937ce47663658e
ToppCell	Sepsis-Bac-SEP-Myeloid-tDC\|Bac-SEP / Disease, condition lineage and cell class	VLDLR CD1C ZNF789 POGK LCLAT1	4.68e-05	199	88	5	a2be40d367338d32348a6906c8475aa3b544a0f7
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD1C IL1R2 GNA15 BCL2 FBXO27	4.68e-05	199	88	5	6fc8c321e2ddd802b9c8edfe16e006c7d4d862fc
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IL1R2 GNA15 FBXO27 LYZ SLC7A14	4.68e-05	199	88	5	26ea06960e8ea061a71756750b84489609f78162
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD1C IL1R2 GNA15 BCL2 NUTM2G	4.68e-05	199	88	5	78e70852acda95d2c770cdd539a46b291f929a78
ToppCell	5'-Adult-SmallIntestine-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK5 SI LCT ACE GLTPD2	4.68e-05	199	88	5	01c2721bc82cd672e9477029b4a7ecc77e2f1b00
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-mDC\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD1C NLRP1 GNA15 LYZ	1.36e-04	132	88	4	f8e2ba53063007d7507f1837ad669b0e4333cd23
ToppCell	metastatic_Brain-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	CD1C IL1R2 KCNH2 LYZ	1.90e-04	144	88	4	6f1158c85e1d50ef6f2c67abdb2dc855a9786b9a
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	SGMS2 ACHE KIAA1958 FBXO27	2.28e-04	151	88	4	4533bccc996395f74b16af939ce79b6fe253c073
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	SGMS2 ACHE KIAA1958 FBXO27	2.28e-04	151	88	4	edb2f59789c295838d2030b80c792cbea25eaa3d
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_3\|390C / Donor, Lineage, Cell class and subclass (all cells)	OTOA CCR5 ACE LYZ	2.34e-04	152	88	4	f717aae4882e9b67e5e40f4ef5b0d35f74a89165
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NOP58 IL1R2 NAV3 CUL9	2.46e-04	154	88	4	b16f3139ce50e70a6a2377b1da7d7877b4000ea1
ToppCell	Control-Epithelial-Ionocyte\|Epithelial / Disease state, Lineage and Cell class	ACHE KCNH1 FAT3 BCL2	2.52e-04	155	88	4	4b9369b203a4d7071c56d3d8e6b450e9a0121c41
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	CD1C DUOX1 SMPD2 LRTM2	2.78e-04	159	88	4	b3c52908cd24bbf851fac69db3850fc7f53c2092
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL1R2 GNA15 LYZ RABGGTA	2.98e-04	162	88	4	88576622af741cf5f754e328bd6d53385ef53be6
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TNFSF11 IL1R2 FBXO27 IL17RB	3.06e-04	163	88	4	476e94e1d132eaaecb9e376bd32748a75ad22081
ToppCell	Influenza_Severe-cDC\|World / Disease group and Cell class	GPR161 CD1C KCNH2 GNA15	3.13e-04	164	88	4	c984228f73b9aa1aaf948541f64f41ed874770cd
ToppCell	Bac-SEP-Myeloid-tDC\|Bac-SEP / Disease, Lineage and Cell Type	VLDLR CD1C ZNF789 LCLAT1	3.20e-04	165	88	4	8728f927502e56f2768b4224e9111939d3d7815a
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK-NK_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	GNA15 BCL2 IL17RB FER1L6	3.27e-04	166	88	4	05d3e7f441089d788a192d7fa1ec5c302d1ca202
ToppCell	Ionocyte-iono-3\|World / Class top	KL TMEM186 COX15 ACE	3.27e-04	166	88	4	9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4
ToppCell	LPS-antiTNF-Myeloid-Dendritic_cells-mDC\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD1C NLRP1 GNA15 LYZ	3.43e-04	168	88	4	2dca1c4a33b6da9357fa3b2a523af19baab1c21c
ToppCell	LPS-antiTNF-Myeloid-Dendritic_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD1C NLRP1 GNA15 LYZ	3.58e-04	170	88	4	3cbeea6bfa500928c413b1c6129f6dedc769cd1e
ToppCell	(7)_MNP-(7)_DC_activated\|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ACHE KCNH2 FAT3 FBXO27	3.58e-04	170	88	4	4ab495b38a071fa8207331df2ce0d78a2dcd034e
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	CD1C GNA15 LRTM2 LYZ	3.58e-04	170	88	4	403b6b749d70d845838dcda7daf99971b50792a2
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 GNA15 SLC7A14 IL17RB	3.75e-04	172	88	4	ce444463f69bbb05c933615a0f1f43ddde3eee1c
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 GNA15 SLC7A14 IL17RB	3.75e-04	172	88	4	2c993a93ac91dcf6061eec001f51f8cccb6ee264
ToppCell	LPS-IL1RA-Myeloid-Dendritic_cells-mDC\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD1C NLRP1 GNA15 LYZ	3.75e-04	172	88	4	cc0e2a45fa74ee19e41612c3615729462474003a
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARFGEF3 KCNJ6 KCNJ11 NUTM2G	3.83e-04	173	88	4	46ed379571385684145b5cb6dd4ae340ac546e64
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB6 GNA15 SLC7A14 IL17RB	3.91e-04	174	88	4	33386750842c47ad7e7286d0f26a556da1a2de02
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	WDR74 IL1R2 LYZ AGTPBP1	3.91e-04	174	88	4	eaaf17a06efc09ed4752b449827b1f0f424d3dad
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB6 GNA15 SLC7A14 IL17RB	3.91e-04	174	88	4	9344d4e76d7d9429aea87d3c0b98246200d16014
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARFGEF3 KCNJ6 KCNJ11 SLC7A14	4.00e-04	175	88	4	c031da47ca63d1133e13530cbf779df9435e22cb
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CD1C IL1R2 LYZ NUTM2G	4.08e-04	176	88	4	a31d7532f8c055d4e62bbaa78d819f2495bfee00
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Mast_cell\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CATSPER1 KCNH2 CLDN20 GNA15	4.08e-04	176	88	4	01ae63366f0a25f46d3c8a3596e0dffdeba54a58
ToppCell	Caecum-Dendritic_cell-cDC1\|Dendritic_cell / Region, Cell class and subclass	EMC1 SETD1B SFI1 RABGGTA	4.08e-04	176	88	4	07cde50e1c18fcc2c5028efe1a087db4ef4d4783
ToppCell	LPS-IL1RA-Myeloid-Dendritic_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD1C NLRP1 GNA15 LYZ	4.08e-04	176	88	4	f3bbe8c1a8d132705eac360cf531261271d84588
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARFGEF3 KCNJ6 KCNJ11 SI	4.17e-04	177	88	4	8dbef0005095c01a806d8c7f723dc48a4650efec
ToppCell	367C-Myeloid-Dendritic-cDC_activated\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ACHE FBXO27 RNF180 SGK2	4.17e-04	177	88	4	a0ff337f11bdb11959ac71805ff94be6b4ec1083
ToppCell	NS-moderate-d_07-13-Epithelial-Ionocyte\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KCNH1 KCNH2 FAT3 CLDN20	4.17e-04	177	88	4	99500aed584f793aaf308f8afbf5d1c6a9b4ee55
ToppCell	normal_Lung-Myeloid_cells-CD163+CD14+_DCs\|normal_Lung / Location, Cell class and cell subclass	CD1C MB21D2 IL1R2 LYZ	4.26e-04	178	88	4	b6dacaad09bf4384d0d4c926fbf769e74a8ec9a9
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SGMS2 FAT3 TRIM17 RNF180	4.26e-04	178	88	4	e32f5ed7a492edfa7073416008b1fcfae6b854ad
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 ACHE FAT3 DNAH1	4.35e-04	179	88	4	479116ac65488c60104a053530830763ec1f95b2
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 ACHE FAT3 DNAH1	4.35e-04	179	88	4	1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILC2\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TNFSF11 CATSPER1 GNA15 IL17RB	4.35e-04	179	88	4	b8bc03f60a7ac76ea6ee90d0512f0dc1d1d2a087
ToppCell	Control-Myeloid-Monocytes,_Macrophages\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD1C NLRP1 GNA15 LYZ	4.35e-04	179	88	4	a79a244bf8ecc333d034b2eb2de554d3310ca6de
ToppCell	Control-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD1C NLRP1 GNA15 LYZ	4.35e-04	179	88	4	c4ff8b191ed0f6dc2dd784869f6f2c62e170a7db
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 ACHE FAT3 DNAH1	4.35e-04	179	88	4	69a1b3b05c921de6343ffe6ad998aa2b804312a7
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARFGEF3 KCNJ6 LRTM2 SLC7A14	4.35e-04	179	88	4	8ce5000088b727783a0619baa16a2cd036d21f54
ToppCell	NS-moderate-d_16-33-Epithelial-Ionocyte\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KCNH1 KCNH2 FAT3 CLDN20	4.45e-04	180	88	4	8af8b4af2dc72223ac71fc027e0d4280c5dd81f8
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	VLDLR SETD1B IL17RB DNAH1	4.45e-04	180	88	4	62511d76d24b836839c3dcc2bf30485ffe9401e2
ToppCell	5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KCNH1 KCNH2 FAT3 LRTM2	4.45e-04	180	88	4	5286e66ff6b7154390b3e9c189704a71d56bc89c
ToppCell	droplet-Kidney-nan-18m-Epithelial-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDUFA13 GPR161 KL AGBL2	4.45e-04	180	88	4	cd743f81838ba210e5bb63fe0870918d7d2b0112
ToppCell	facs-SCAT\|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUOX1 IL1R2 WNT2 ACE	4.45e-04	180	88	4	6c70b6b7480507fa94625013222ad338ee7dd1d9
ToppCell	Control-Myeloid-Dendritic_cells\|Control / group, cell type (main and fine annotations)	CD1C MB21D2 IL1R2 BCL2	4.45e-04	180	88	4	25ad95c3c30e3b82abe93bd77ba003f5c2241f7c
ToppCell	CV-Severe-4\|Severe / Virus stimulation, Condition and Cluster	TARS3 TNFSF11 GNA15 GDE1	4.45e-04	180	88	4	cf84a01e6a33e5d27ad7be1d9069a0370b5116d1
ToppCell	5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KCNH1 KCNH2 FAT3 LRTM2	4.45e-04	180	88	4	2b6b295b5c21b829828afae9ab4c3eb9233f6f45
ToppCell	5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KCNH1 KCNH2 FAT3 LRTM2	4.45e-04	180	88	4	bf587387145a2b5e83766fbccf76eecc6d5e8241
ToppCell	Control-Myeloid\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD1C NLRP1 GNA15 LYZ	4.54e-04	181	88	4	25170e5285996cc80337d5f86a0255569861ae77
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TARS3 BCL2 SSR3 RIC1	4.63e-04	182	88	4	626aabfd9ac662c1d189f7c4b660482914d9e669
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	VLDLR SETD1B IL17RB DNAH1	4.63e-04	182	88	4	03992d0ae519795239e4f2cc8e63f33c4482de6a
ToppCell	metastatic_Lymph_Node-Myeloid_cells-CD1c+_DCs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	CD1C IL1R2 GNA15 LYZ	4.63e-04	182	88	4	551d301adfb4d5046c5f60f6996450621b04e9b2
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TARS3 BCL2 SSR3 RIC1	4.63e-04	182	88	4	a00abff41c12b71d5860c494b8c722d649fd5f36
ToppCell	CV-Severe-4\|CV / Virus stimulation, Condition and Cluster	TARS3 TNFSF11 GNA15 GDE1	4.63e-04	182	88	4	c19bbc43d97c426aec37414f46f667a19b62a257
Drug	Trifluoperazine	TNFSF11 ACHE KCNH2 RPS6KB1 BCL2	2.28e-07	35	88	5	ctd:D014268
Drug	Carbachol	ACHE KCNJ6 RPS6KB1 BCL2 LYZ	2.51e-06	56	88	5	ctd:D002217
Drug	Bromperidol [10457-90-6]; Down 200; 9.6uM; HL60; HG-U133A	UBR2 EMC1 TM9SF4 MR1 RIOK3 NLRP1 MAPK8IP3	1.07e-05	195	88	7	1723_DN
Drug	3-fluorotyrosine	MR1 SI STT3B	1.20e-05	12	88	3	CID000092100
Drug	desmethylastemizole	KCNH1 KCNH2	1.48e-05	2	88	2	ctd:C040463
Drug	glycylmethionylglycine	LYZ STT3B	1.48e-05	2	88	2	CID003016679
Drug	xaliproden	ACHE KCNH2	1.48e-05	2	88	2	ctd:C462299
Drug	Benperidol	KCNH1 KCNH2	1.48e-05	2	88	2	ctd:D001544
Drug	matrine	CATSPER1 KCNH2 BCL2	1.97e-05	14	88	3	ctd:C034244
Drug	p-nitrophenyl	KL MAN2C1 ACHE SI LCT LYZ	2.21e-05	146	88	6	CID000007416
Drug	hex-2-ene	ACHE KCNJ6 LCT	3.01e-05	16	88	3	CID000019966
Disease	amino acid metabolic disorder (implicated_via_orthology)	TARS3 TARS1	4.90e-05	4	85	2	DOID:9252 (implicated_via_orthology)
Disease	Developmental Academic Disorder	KL ACHE BCL2	7.99e-05	29	85	3	C1330966
Disease	Learning Disorders	KL ACHE BCL2	7.99e-05	29	85	3	C0023186
Disease	Learning Disturbance	KL ACHE BCL2	7.99e-05	29	85	3	C0751263
Disease	Adult Learning Disorders	KL ACHE BCL2	7.99e-05	29	85	3	C0751262
Disease	Learning Disabilities	KL ACHE BCL2	7.99e-05	29	85	3	C0751265
Disease	monocyte measurement	KCNJ6 RPS6KB1 LYZ METTL17	9.45e-05	82	85	4	EFO_0803547
Disease	neutrophil count	UBR2 VLDLR CD1C IL1R2 MRPS14 PCDHA8 RIOK3 GNA15 BCL2 AGBL2 LCT LYZ SDHC	1.57e-04	1382	85	13	EFO_0004833
Disease	interleukin 9 measurement	KLHDC1 KCNJ6 RTTN	2.62e-04	43	85	3	EFO_0008192
Disease	Memory Loss	KL ACHE BCL2	2.62e-04	43	85	3	C0751295
Disease	Age-Related Memory Disorders	KL ACHE BCL2	2.62e-04	43	85	3	C0751292
Disease	Memory Disorder, Spatial	KL ACHE BCL2	2.62e-04	43	85	3	C0751294
Disease	Memory Disorder, Semantic	KL ACHE BCL2	2.62e-04	43	85	3	C0751293
Disease	Memory Disorders	KL ACHE BCL2	2.62e-04	43	85	3	C0025261
Disease	Memory impairment	KL ACHE BCL2	2.81e-04	44	85	3	C0233794
Disease	alcohol dependence (implicated_via_orthology)	RPS6KB1 RPS6KB2	2.91e-04	9	85	2	DOID:0050741 (implicated_via_orthology)
Disease	Mitochondrial Diseases	NDUFA13 COX15 SDHC	3.86e-04	49	85	3	C0751651
Disease	hypertension (biomarker_via_orthology)	KL KCNJ11 CCR5 BCL2 ACE	5.13e-04	227	85	5	DOID:10763 (biomarker_via_orthology)
Disease	Alzheimer's disease (implicated_via_orthology)	CCR5 BCL2 ACE	6.03e-04	57	85	3	DOID:10652 (implicated_via_orthology)
Disease	Hypercalcemia	KL TNFSF11	6.27e-04	13	85	2	C0020437
Disease	Milk-Alkali Syndrome	KL TNFSF11	6.27e-04	13	85	2	C0026141
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	KL KCNJ11 CCR5 BCL2	8.75e-04	147	85	4	DOID:9352 (biomarker_via_orthology)
Disease	sarcoidosis (is_implicated_in)	CCR5 ACE	9.59e-04	16	85	2	DOID:11335 (is_implicated_in)
Disease	type 1 diabetes mellitus (is_marker_for)	ACHE CCR5 ACE	1.19e-03	72	85	3	DOID:9744 (is_marker_for)
Disease	end stage renal disease (implicated_via_orthology)	BCL2 ACE	1.51e-03	20	85	2	DOID:783 (implicated_via_orthology)
Disease	Nerve Degeneration	KCNJ6 BCL2 AGTPBP1	1.80e-03	83	85	3	C0027746
Disease	dilated cardiomyopathy (biomarker_via_orthology)	RPS6KB1 BCL2	1.82e-03	22	85	2	DOID:12930 (biomarker_via_orthology)
Disease	Kidney Diseases	PCSK5 KL ACE	2.12e-03	88	85	3	C0022658
Disease	Cardiac Arrhythmia	KCNH2 ACE	2.36e-03	25	85	2	C0003811
Disease	colon adenocarcinoma (is_marker_for)	PCSK5 BCL2	2.36e-03	25	85	2	DOID:234 (is_marker_for)
Disease	corpus collosum mid-posterior volume measurement	VLDLR AGBL2	2.36e-03	25	85	2	EFO_0010300
Disease	Left Ventricular Hypertrophy	RPS6KB1 ACE	2.36e-03	25	85	2	C0149721
Disease	waist-hip ratio	PCSK5 WNT2 KCNJ6 MRPS14 NAV3 CLDN20 CUL9 RIOK3 BCL2 SSR3	2.74e-03	1226	85	10	EFO_0004343

Protein segments in the cluster

Peptide	Gene	Start	Entry
ERQWKAEFHRWSSYM	ACHE	581	P22303
DWSLIYMDSRAQGAW	CATSPER1	631	Q8NEC5
SYAMLLFAWEGWHNA	ACE	181	P12821
LDAWYGARDWALNHL	ACTR5	531	Q9H9F9
WAHYAAAQWDFGNTM	CCR5	86	P51681
WWIRMGTDICYYKNH	AGTPBP1	796	Q9UPW5
QLHGLWMDCTWYSTG	CLDN20	46	P56880
KINSMSWGAEGYHLW	RIC1	361	Q4ADV7
MAGNFWQSSHYLQWI	CCNC	1	P24863
RFDGWYNNLMEHRWG	DUOX1	31	Q9NRD9
SWVSAEHLWVLGRYM	OTOA	251	Q7RTW8
LNNYIMRCREWYGWH	NOP58	176	Q9Y2X3
MDYHWRGELGSWRLL	PCDHA8	1	Q9Y5H6
WMCLAKWESGYNTRA	LYZ	46	P61626
AVAQSWLMENHFWDG	MB21D2	246	Q8IYB1
EHYWSLVAMAAWERR	GLTPD2	146	A6NH11
MWLGAQNGWLYVHSA	MAPK8IP3	971	Q9UPT6
WWLIAYIRGDMDHIE	KCNJ6	111	P48051
ATWVLVAGIYLMWRH	IL17RB	301	Q9NRM6
AHWLACIWYAIGNME	KCNH2	561	Q12809
WAMQAAAYIFIHRKW	LCLAT1	161	Q6UWP7
FAMAWWLIAFAHGDL	KCNJ11	86	Q14654
NWEFMTIHCWGERAA	PCSK5	551	Q92824
LVWRYGFQSLRMHMW	PCYOX1	141	Q9UHG3
ADNGTMHLWDWRTGY	PLRG1	431	O43660
MHLWDWRTGYNFQRV	PLRG1	436	O43660
AWDLALHTWEQMGLR	NLRP1	66	Q9C000
EGSRVWFMDLWNYSL	NAV3	2251	Q8IVL0
GTLIYGHWSIMKWNR	NDUFA13	41	Q9P0J0
FGLAAHWMACIWYSI	KCNH1	386	O95259
MRSGHNRAVDWWSLG	RPS6KB1	266	P23443
NRAVDWWSLGALMYD	RPS6KB1	271	P23443
RGYVAWSLMDNFEWL	LCT	1311	P09848
YAAAMQWLWRDAGIR	GNA15	131	P30679
HRYGWMTEDLMQDWL	POGK	436	Q9P215
GMAQARWWATFASYV	SMPD2	316	O60906
ELLRQWMDHGGWYDR	DNAH1	2311	Q9P2D7
LLDWSMHNILWYLCG	GDE1	256	Q9NZC3
LRVLEVSNHWWYSML	KDM1B	191	Q8NB78
DIILYWGHHFSMNWI	CD1C	291	P29017
WLRRSHKDHSYWDMA	ARFGEF3	1511	Q5TH69
YHTWNGIRHLMWDLG	SDHC	126	Q99643
AYHWDTSDWMPGARL	FAT3	4351	Q8TDW7
DFHSCLGWMQWRGLS	AGBL2	96	Q5U5Z8
ARFEVWAHRWMDLSE	MAN2C1	846	Q9NTJ4
WAHRWMDLSEHGFGL	MAN2C1	851	Q9NTJ4
WMCVAAWHREPGYTA	GPR161	176	Q8N6U8
IWTYDIDSGLWRMHL	KLHDC1	46	Q8N7A1
MNDLHYLNLDTWTWS	KLHDC1	221	Q8N7A1
TAWSLMDGFEWHRGY	KL	456	Q9UEF7
QSTGRTYWVHWHMLE	CUL9	421	Q8IWT3
QAWTSHLWKMFYDAR	EMC1	496	Q8N766
WYMEYSHRMWGRLVG	COX15	146	Q7KZN9
WWGARHDSGCMYRLL	FBXO27	191	Q8NI29
WAAHSIWGQSLREYM	METTL17	201	Q9H7H0
RMDYLHFEDDSRGWW	RNF180	546	Q86T96
WMAENLAPDHWERYT	MR1	71	Q95460
GLWRAMREWQHTSNF	NUTM2G	256	Q5VZR2
SWGDQTFRLHWSNML	FER1L6	586	Q2WGJ9
LRIAWNLSWYHGSDN	RTTN	1021	Q86VV8
LWEASGHWQHYSENM	TARS3	461	A2RTX5
RLWMTSGHWQHYSEN	TARS1	381	P26639
HAERQLLYRSWFMWH	SFI1	546	A8K8P3
LLYRSWFMWHQQAAA	SFI1	551	A8K8P3
DWWCLGAVLYEMLHG	SGK2	216	Q9HBY8
HNRAVDWWSLGALMY	RPS6KB2	246	Q9UBS0
HWMEWFSYRGGRLDQ	LRTM2	211	Q8N967
QSAWFYHRWLLGRAD	RABGGTA	226	Q92696
LWFEVQGSALMLHWR	EPHB6	376	O15197
MDWLNDTLWVYHPST	SETD1B	1711	Q9UPS6
HWLGDNYARWDNMDK	SI	1496	P14410
RLFWWYHSMANEKNL	SGMS2	286	Q8NHU3
MLWWTANDTHIESAY	IL1R2	271	P27930
LYWRIWHMDLIQSAV	SSR3	46	Q9UNL2
WMTEYLNRHLHTWIQ	BCL2	176	P10415
DLSEYNMLWHAGKVW	RIOK3	406	O14730
RRVQWGAAWYAMHSR	SLC7A14	11	Q8TBB6
ASGQVRSHYVDWRMW	MRPS14	21	O60783
MAAAAARWNHVWVGT	WDR74	1	Q6RFH5
WLAMADFRKTGDYLW	WNT2	221	P09544
IPAWWVSMDAYLNHA	XKRY	106	O14609
RWDTYLTMSDVQIHW	TM9SF4	266	Q92544
DEHARVMSWWDYGYQ	STT3B	596	Q8TCJ2
SGTMLRVAHLNFWGW	TMEM186	136	Q96B77
LWHMRNNFLFGSRCW	MTERF1	26	Q99551
LFWWEYEHNNRKMSG	GTF3C4	316	Q9UKN8
SWYHDRGWAKISNMT	TNFSF11	186	O14788
HYWEVGMNITGDALW	TRIM17	351	Q9Y577
QWAVEHNGYAWSESM	UBR2	906	Q8IWV8
LQGDAWHLRKMDWCY	USP40	881	Q9NVE5
VAMYFTREEWGHLNW	ZNF789	16	Q5FWF6
AAVGGYLMWRNWQHK	VLDLR	811	P98155
WRYWCMTNGLKDHTD	KIAA1958	431	Q8N8K9